within Pharmacolibrary.Drugs.V_Various.V09H_InflammationAndInfectionDetection.V09HA01_Technetium99mtcHumanImmunoglobulin;

model Technetium99mtcHumanImmunoglobulin
  extends Pharmacolibrary.Drugs.ATC.V.V09HA01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V09HA01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Technetium (99mTc) human immunoglobulin is a diagnostic radiopharmaceutical agent composed of human immunoglobulin G labeled with technetium-99m. It is primarily used as a radiotracer in nuclear medicine for the imaging of inflammatory lesions and infection. The preparation is not intended for therapeutic use but for diagnostic purposes. Technetium (99mTc) human immunoglobulin is approved in several countries for scintigraphic detection of inflammation and infection sites.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult subjects based on radiolabeled immunoglobulin imaging agents. No direct peer-reviewed PK dataset for technetium (99mTc) human immunoglobulin was found; values here are based on analogy with similar radiolabeled human IgG imaging agents.</p><h4>References</h4><ol><li><p>Shanthly, N, et al., &amp; Thakur, ML (2006). 99mTc-Fanolesomab: affinity, pharmacokinetics and preliminary evaluation. <i>The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...</i> 50(2) 104–112. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16770300/\">https://pubmed.ncbi.nlm.nih.gov/16770300</a></p></li><li><p>De Leiris, N, et al., &amp; Moulin, M (2024). A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization. <i>Journal of translational medicine</i> 22(1) 163–None. DOI:<a href=\"https://doi.org/10.1186/s12967-024-04987-1\">10.1186/s12967-024-04987-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38365700/\">https://pubmed.ncbi.nlm.nih.gov/38365700</a></p></li><li><p>Gano, L, et al., &amp; Hnatowich, DJ (1998). Human polyclonal immunoglobulin labelled with technetium-99m via NHS-MAG3: a comparison of radiochemical behavior and biological efficacy with other labelling methods. <i>Nuclear medicine and biology</i> 25(4) 395–403. DOI:<a href=\"https://doi.org/10.1016/s0969-8051(97)00225-4\">10.1016/s0969-8051(97)00225-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9639302/\">https://pubmed.ncbi.nlm.nih.gov/9639302</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Technetium99mtcHumanImmunoglobulin;
